Department of Pediatrics, Lillie Frank Abercrombie Section of Pediatric Cardiology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.
University of Texas Southwestern Medical School, Dallas, Texas.
J Card Fail. 2019 Dec;25(12):941-947. doi: 10.1016/j.cardfail.2019.03.019. Epub 2019 Apr 12.
Loop diuretics are considered first-line therapy for congestion in children with heart failure, although some patients remain volume overloaded during treatment. We sought to characterize loop diuretic responsiveness (DR) in children hospitalized with acute decompensated failure and to determine whether a decreased response was associated with worse outcomes.
DR was calculated for 108 consecutive children ˂21 years of age who were hospitalized with acute decompensated heart failure. DR was defined as net fluid (mL) output per 1 mg of furosemide equivalents during the first 72 hours of treatment with a loop diuretic. The primary outcome was the composite end point of inpatient death or use of mechanical circulatory support. The median DR was 6.0 mL/mg (interquartile range -2.4 to 15.7 mL/mg). Thirty-two percent of patients remained in a positive fluid balance after 72 hours of treatment with a loop diuretic. Death or use of mechanical circulatory support occurred in 29 patients (27%). Low DR was associated with the composite end point, even after adjusting for net urine output and loop diuretic dose indexed to weight (odds ratio 5.3; P = .003). Patients with low DR also experienced longer length of hospital stay than patients with greater DR (median 33 days vs 11 days; P = .002).
In children hospitalized with acute decompensated heart failure, early diminished loop DR during decongestion therapy is common and portends a poor prognosis.
袢利尿剂被认为是心力衰竭儿童充血的一线治疗药物,尽管在治疗过程中仍有一些患者存在容量超负荷。我们试图描述因急性失代偿性心力衰竭住院的儿童中袢利尿剂反应(DR)的特征,并确定反应减弱是否与预后不良相关。
对 108 名连续就诊于急性失代偿性心力衰竭的年龄小于 21 岁的儿童进行了 DR 计算。DR 定义为袢利尿剂治疗的前 72 小时内每 1mg 呋塞米当量的净液体(mL)输出。主要结局是住院期间死亡或使用机械循环支持的复合终点。DR 的中位数为 6.0mL/mg(四分位距-2.4 至 15.7mL/mg)。32%的患者在袢利尿剂治疗 72 小时后仍处于正液体平衡状态。29 名患者(27%)发生死亡或使用机械循环支持。即使在调整了净尿量和按体重指数计算的袢利尿剂剂量后,低 DR 仍与复合终点相关(比值比 5.3;P=0.003)。与 DR 较高的患者相比,低 DR 患者的住院时间也更长(中位数 33 天 vs 11 天;P=0.002)。
在因急性失代偿性心力衰竭住院的儿童中,在利尿消肿治疗期间早期出现袢利尿剂 DR 降低是很常见的,预示着预后不良。